FDA rejects gallstone shock treatment:
This article was originally published in Clinica
Executive Summary
The FDA rejected a premarketing approval application for a shockwave therapy device for breaking up gallstones despite a recommendation from its own advisory panel. Medstone International, the Aliso Veijo, California-based company which makes the device, said it is "deeply disappointed" with the decision and plans to respond to the agency.